Endeavor BioMedicines
PrivateLast Round
Series C
Apr 24, 2024
Total Funding Raised
$295.5M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Endeavor BioMedicines is a biotechnology company that develops precision medicines targeting the underlying genetic and cellular causes of life-threatening diseases such as pulmonary fibrosis and cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Endeavor BioMedicines Comparables
Compare Endeavor BioMedicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Insilico Medicine | 81% | |
| PureTech Health | 78% | |
| Contineum Therapeutics | 77% |
Endeavor BioMedicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 24, 2024 | ||||
| Series B | Feb 7, 2022 | ||||
| Series A | Jan 7, 2021 |
Key People
Founding team and executive leadership
Endeavor BioMedicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Longitude Capital | Series C, Series B, Series A |
| Aberdeen Group plc | Series C |
| SymBiosis Capital Management | Series C |
| Omega Funds | Series C, Series B, Series A |
| Eckuity | Series C |
| Perceptive Advisors | Series C, Series B |
| abrdn Inc. | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 68% MoM.
- May 1, 2025
Two posters accepted for American Thoracic Society 2025 International Conference.
Recent news
Latest coverage and updates
- attends_eventSep 8, 2026
Endeavor BioMedicines attended event ERS congress on Sep 8th '26.
- attends_eventSep 8, 2026
Endeavor BioMedicines attended event European Respiratory Society (ERS) Conference on Sep 8th '26.
Endeavor BioMedicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Endeavor BioMedicines's valuation, stock price, and market status.
Is Endeavor Biomedicines a public or private company?
Endeavor Biomedicines is a private company.
What is the current stock price of Endeavor Biomedicines?
Endeavor Biomedicines is a private company with no public stock price. No recent secondary market data is available.
How much is Endeavor Biomedicines worth (valuation)?
Valuation information for Endeavor Biomedicines is not publicly available.
Can I buy Endeavor Biomedicines stock?
Endeavor Biomedicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Endeavor Biomedicines's last funding round?
Endeavor Biomedicines's most recent funding round was Series C on April 24, 2024.
Who are the main investors in Endeavor Biomedicines?
Key investors in Endeavor Biomedicines include Longitude Capital, Omega Funds, Avidity Partners.
Will Endeavor Biomedicines IPO soon?
No public IPO plans have been announced for Endeavor Biomedicines.
How can I track Endeavor Biomedicines secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Endeavor Biomedicines's secondary market activity and sign up for updates.